Citius Oncology Inc.CTORNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-32.90%
↓ 1753% vs avg
Percentile
P21
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
1.99%
Historical baseline
PeriodValue
Q4 2025-32.90%
Q3 20250.00%
Q2 20250.00%
Q1 20250.00%
Q4 2024-100.00%
Q3 2024347.29%
Q2 2024-89.92%
Q1 202412.15%
Q4 2023-106.76%
Q3 20230.00%
Q2 20230.00%
Q1 20230.00%
Q4 20220.00%
Q3 20220.00%
Q2 20220.00%